BioSpace News Archive

MichBio welcomes Lola Eniola-Adefeso, PhD, University Diversity and Social Transformation Professor of Chemical Engineering at the University of Michigan to its Board of Directors.

The Hanukkah Special Gift Pack is Strictly Limited to 613 Units and is Priced at $106.13 per Unit

Phoenix Molecular Designs (PhoenixMD), an industry leader in the development of precise cancer therapeutics focusing on first-in-class RSK kinase inhibitors, today announced that the first patient has been dosed in their Phase 1b clinical trial of PMD-026

DEKA M.E.L.A. Srl, a laser and opto-electronics company engaged in the development of gynecological energy based devices and therapies for the treatment of women health diseases, announced the establishment of its Medical Advisory Board for Female Intimate Health.

180 Life Sciences Corp., a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced that it will ring the Nasdaq Stock Exchange opening bell on November 27, 2020, in celebration of its recently completed initial public offering.

City of Hope has initiated a phase 1 clinical trial that will test one of its investigational SARS-CoV-2 vaccines in healthy volunteers between the ages of 18 and 55 who have not had COVID-19.

Jupiter Wellness, Inc.announced today they are initiating a clinical study of its CaniSun™ sunscreen lotion for the treatment of actinic keratosis (AK), the most common precancer that forms on the skin as a result of exposure to ultraviolet (UV) rays.

Annual program honors individuals for their outstanding efforts in making a difference for patients living with myeloproliferative neoplasms (MPNs)

Remotely controlled hospital wards may sound like something out of science fiction, but they’re already becoming reality, and an innovation that could save time and even lives during the COVID-19 pandemic.

Eli Lilly and Company will participate in the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020.